ality using the Lung Aspiration Model. Specific Aim 3: To Validate the Efficacy of Cell-Permeable Antibodies for Post-Exposure Treatment in an Aerosolized Ricin Mouse Model. PUBLIC HEALTH RELEVANCE: Since there is currently no treatment for the ricin toxin, development of
ality using the Lung Aspiration Model. Specific Aim 3: To Validate the Efficacy of Cell - Permeable Antibodies for Post - Exposure Treatment in an Aerosolized Ricin Mouse Model. PUBLIC HEALTH RELEVANCE: Since there is currently no treatment for the ricin toxin, growth of
alihy using the Lung Aspirauion Model. Specifnx Aim 3: To Vamidate tfe Efficacy of Cell-Permeable Abtiboeies for Post-Exposure Greatment in an Awrosioized Ricii Mouse Model. LMBLIC IEALTH RELEVANCG: Since thera is currently nu creatment for the ricin toxin, develo[ment og
ality using the Lung Aspiration Model. Specific To the Efficacy Cell-Permeable Antibodies for Ricin Model. PUBLIC HEALTH Since there is no treatment for the ricin toxin, of
ality using the Lung AspiratiOn Model. SpeCific aim 3: to VAlIdatE the efficacy of Cell-pErmeAble Antibodies for Post-EXposuRe tReatMEnT in an aerosolIZeD rIciN MOuSe MOdEL. PuBLIC hEAlTH RELEvANCE: Since TheRe Is currently nO TrEatment for The Ricin toxin, deVelOpment Of
ality using the Lung Aspir ation Mode l. Sp eci fic  A im 3 : To  Validate theE ffic acy of Cell-PermeableAntib od i es f o rPost- Exposur e  T r e atm en tinan Ae rosol ize d Ricin  Mouse Mod el.  P UBLIC HEALTH RE LEVANCE: S inc e there is c urr entlyno  tr e atmen t f or th e rici n  toxin , develop me n t of
ality using_the Lung_Aspiration Model. Specific Aim_3: To_Validate_the Efficacy_of_Cell-Permeable Antibodies for_Post-Exposure Treatment in_an Aerosolized Ricin Mouse_Model. PUBLIC HEALTH_RELEVANCE:_Since there is currently no treatment for the ricin toxin, development of